Abstract
Mesenchymal stem cells (MSCs) possess well-known reparative properties, among which the ability to form neovessels; in vivo, this characteristic is carried out both in a normal and in a pathological setting. Hypoxia, a condition common to many human diseases, is known to promote angiogenesis and to improve stem cell proliferation and differentiation. For this purpose, we provide an experimental protocol to test stem cell viability and angiogenesis under hypoxic conditions, comparing a vascular model of MSCs with stable cell lines. In order to avoid the use of expensive facilities, we propose the application of a chemical hypoxia inducer, cobalt chloride.
*Author contributed equally with all other contributors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hemat 28:875–884
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
Fischer MP, Levin S, Zipori D (2011) The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev and Rep 7:560–568. doi:10.1007/s12015-011-9229-7
Liu J, Hao H, Xia L et al (2015) Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia. Plos One 10(5):e0126715. doi:10.1371/journal.pone.0126715
Wu D, Yotnda P (2011) Induction and testing of hypoxia in cell culture. JoVE 54:2899. doi:10.3791/2899
Krock BL, Skuli N, Simon MC (2011) Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2:1117–1133. doi:10.1177/1947601911423654
Ciavarella C, Fittipaldi S, Pedrini S et al (2015) In vitro alteration of physiological parameters do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells. Frontiers. 3. doi: 10.3389/fcell.2015.00036
Webber MM, Trakul N, Thraves PS et al (1999) A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. Carcinogenesis 20:1185–1192
Arnaoutova I, George J, Kleinman HK, Benton G (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12:267–274. doi:10.1007/s10456-009-9146-4
Fittipaldi S, Vasuri F, Degiovanni A et al (2014) Nestin and WT1 expression in atheromatous plaque neovessels: association with vulnerability. Histol Histopathol 29:1565–1573
Vasuri F, Fittipaldi S, Giunchi F et al (2015) Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. J Clin Path. 0:1–7. doi: 10.1136/jclinpath-2015-203028 [Epub ahead of print]
Valente S, Alviano F, Ciavarella C et al (2014) Human cadaver multipotent stromal/stem cells isolated from arteries stored in liquid nitrogen for 5 years. Stem Cell Res Ther 5:8. doi:10.1186/scrt397
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ciavarella, C., Fittipaldi, S., Pasquinelli, G. (2016). CoCl2 Administration to Vascular MSC Cultures as an In Vitro Hypoxic System to Study Stem Cell Survival and Angiogenesis. In: Turksen, K. (eds) Stem Cell Heterogeneity. Methods in Molecular Biology, vol 1516. Humana Press, New York, NY. https://doi.org/10.1007/7651_2016_350
Download citation
DOI: https://doi.org/10.1007/7651_2016_350
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6549-6
Online ISBN: 978-1-4939-6550-2
eBook Packages: Springer Protocols